表紙:口内炎治療の世界市場 - 産業規模、シェア、動向、機会、予測:薬剤クラス別、剤形別、症状別、地域別(2017年~2027年)
市場調査レポート
商品コード
1171629

口内炎治療の世界市場 - 産業規模、シェア、動向、機会、予測:薬剤クラス別、剤形別、症状別、地域別(2017年~2027年)

Mouth Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class, By Formulation, By Indication, By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

口内炎治療の世界市場 - 産業規模、シェア、動向、機会、予測:薬剤クラス別、剤形別、症状別、地域別(2017年~2027年)
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の口内炎治療の市場規模は、予測期間中に着実な成長を遂げると予測されています。

世界の人々の間で口内炎の有病率が高まっていることが、市場成長の要因です。また、世界の高齢者人口の増加が、市場成長を支えると期待されています。加齢に伴う免疫力の低下により、年齢とともに口内炎を含む様々な病気にかかりやすくなり、このことが、予測期間中の世界の口内炎治療市場の成長を後押ししています。

当レポートでは、世界の口内炎治療市場について調査分析し、セグメント別・地域別の市場規模・シェア予測、市場力学、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の口内炎治療市場に対するCOVID-19の影響

第5章 VOC (顧客の声)

第6章 世界の口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬剤クラス別(抗菌剤、抗ヒスタミン剤、鎮痛剤、コルチコステロイド、その他)
    • 剤形別(マウスウォッシュ、トローチ、軟膏、スプレー、ジェル)
    • 症状別(アフタ性口内炎、口腔扁平苔癬、その他)
    • 企業別(2021年)
    • 地域別
  • 市場マップ

第7章 北米の口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬物クラス別
    • 剤形別
    • 症状別
    • 国別
  • 国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬物クラス別
    • 剤形別
    • 症状別
    • 国別
  • 国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋の口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬物クラス別
    • 剤形別
    • 症状別
    • 国別
  • 国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬物クラス別
    • 剤形別
    • 症状別
    • 国別
  • 国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの口内炎治療市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 薬物クラス別
    • 剤形別
    • 症状別
    • 国別
  • 国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開発

第14章 競合情勢

  • 3M Company
  • GlaxoSmithKline, plc
  • Bristol-Myers Squibb Company
  • Colgate Palmolive Company
  • Blistex Inc
  • Church & Dwight Co, Inc.
  • Dr. Reddy's Laboratories Limited
  • Patterson Dental Supply Inc.
  • Pfizer Inc.
  • Prince Care Pharma Private Limited

第15章 戦略的提言

目次
Product Code: 12876

The global mouth ulcer treatment market expected to witness a steady growth during the forecast period. This can be ascribed to the growing prevalence of mouth ulcers among population worldwide. Mouth ulcers are basically sores that are formed on the soft tissue in the mouth including lips, cheek, gums, tongue, etc. These sores are often painful. Mouth ulcer can be caused due to various factors including consumption of food items containing higher amount of acids, deficiency of vitamins, among others. Sometimes, braces and poor fitted dentures can also cause mouth ulcers. Besides, stress and anxiety can also contribute to mouth ulcers. Hence, all these factors are expected to increase the demand for mouth ulcer treatment in the coming years.

Growing Geriatric Population

The increasing geriatric population across the globe is expected to support the market growth. Susceptibility to different diseases including mouth ulcer increases with age on account of reducing immunity with aging. This in turn is driving the growth of global mouth ulcer treatment market during the forecast period. According to United Nations, Department of Economic and Social Affairs, Population Division, Number of Persons Aged 65 Years or Above in 2019 were around 702.9 million and this number is expected to increase to 1548.9 million by 2050.

New Product Launches

Major players operating in the global mouth ulcer treatment market are focusing on producing various innovative drugs with fewer side effects and fast healing action. This has made companies develop diverse medication options related to mouth ulcers, such as pastes, antibiotic mouthwashes, creams, and gels to prevent recurring ulcerations. For instance, Oralixir Mouth Wash, Orajel Mouth Sore Gel, Clotrin mouth paint are advanced products available in the market for the treatment of oral ulcers. Additionally, various academic & research organizations across the globe are also focusing on development of new products related to mouth ulcers. According to clinicaltrials.gov, around 97 clinical trials related to mouth ulcer treatment are in same phases of development. This in turn is expected to create lucrative opportunities for the market growth during forecast period.

Increasing Oral Problems

The changing lifestyle and eating patterns of population across the globe has significantly increased the prevalence of different oral problems including mouth ulcers. The presence of synthetic chemicals and higher concentration of acids in different food items lead to mouth ulcers, thereby driving the growth of global mouth ulcer treatment market. Although different organizations across the globe are taking initiatives to create awareness related to oral health and hygiene, but the increase in consumption of nicotine-based products, smoking and tobacco is contributing to various oral problems including mouth ulcers. According to a report published by World Health Organization (WHO) in 2020, around 22.30% people consumed tobacco. Tobacco contributes to mouth ulcers thereby driving the market growth.

Market Segmentation

The global mouth ulcer treatment market can be segmented by drug class, by formulation, by indication, by region. Based on drug class, the market can be categorized into antimicrobial, antihistamine, analgesics & corticosteroids, and others. Based on formulation, the market can be differentiated into mouthwash, lozenges, ointment, spray, and gel. Based on indication, the market can be categorized into aphthous stomatitis, oral lichen planus, and others. Regionally, North America region dominated the global mouth ulcer treatment market in 2021 among Europe, Asia Pacific, South America, and Middle East & Africa region. While United States, dominated the market among different across the globe on account of the growing prevalence of different oral problems.

Market Players

3M Company, GlaxoSmithKline, plc, Bristol-Myers Squibb Company, Colgate Palmolive Company, Blistex Inc, Church & Dwight Co, Inc., Dr. Reddy's Laboratories Limited, Patterson Dental Supply Inc., Pfizer Inc., Prince Care Pharma Private Limited are some of the leading players operating in the global mouth ulcer treatment market.

Report Scope

In this report, global mouth ulcer treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Mouth Ulcer Treatment Market, By Drug Class:

  • Antimicrobial
  • Antihistamine
  • Analgesics & Corticosteroids
  • Others

Mouth Ulcer Treatment Market, By Formulation:

  • Mouthwash
  • Lozenges
  • Ointment
  • Spray
  • Gel

Mouth Ulcer Treatment Market, By Indication:

  • Aphthous Stomatitis
  • Oral Lichen Planus
  • Others

Mouth Ulcer Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global mouth ulcer treatment market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Mouth Ulcer Treatment Market

5. Voice of Customer

6. Global Mouth Ulcer Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Class (Antimicrobial, Antihistamine, Analgesics & Corticosteroids, Others)
    • 6.2.2. By Formulation (Mouthwash, Lozenges, Ointment, Spray, Gel)
    • 6.2.3. By Indication (Aphthous Stomatitis, Oral Lichen Planus, Others)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Mouth Ulcer Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Class
    • 7.2.2. By Formulation
    • 7.2.3. By Indication
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Mouth Ulcer Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Class
        • 7.3.1.2.2. By Formulation
        • 7.3.1.2.3. By Indication
    • 7.3.2. Canada Mouth Ulcer Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Class
        • 7.3.2.2.2. By Formulation
        • 7.3.2.2.3. By Indication
    • 7.3.3. Mexico Mouth Ulcer Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Class
        • 7.3.3.2.2. By Formulation
        • 7.3.3.2.3. By Indication

8. Europe Mouth Ulcer Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Class
    • 8.2.2. By Formulation
    • 8.2.3. By Indication
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Mouth Ulcer Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Class
        • 8.3.1.2.2. By Formulation
        • 8.3.1.2.3. By Indication
    • 8.3.2. Germany Mouth Ulcer Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Class
        • 8.3.2.2.2. By Formulation
        • 8.3.2.2.3. By Indication
    • 8.3.3. United Kingdom Mouth Ulcer Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Class
        • 8.3.3.2.2. By Formulation
        • 8.3.3.2.3. By Indication
    • 8.3.4. Italy Mouth Ulcer Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Class
        • 8.3.4.2.2. By Formulation
        • 8.3.4.2.3. By Indication
    • 8.3.5. Spain Mouth Ulcer Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Class
        • 8.3.5.2.2. By Formulation
        • 8.3.5.2.3. By Indication

9. Asia-Pacific Mouth Ulcer Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Class
    • 9.2.2. By Formulation
    • 9.2.3. By Indication
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Mouth Ulcer Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Class
        • 9.3.1.2.2. By Formulation
        • 9.3.1.2.3. By Indication
    • 9.3.2. India Mouth Ulcer Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Class
        • 9.3.2.2.2. By Formulation
        • 9.3.2.2.3. By Indication
    • 9.3.3. Japan Mouth Ulcer Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Class
        • 9.3.3.2.2. By Formulation
        • 9.3.3.2.3. By Indication
    • 9.3.4. South Korea Mouth Ulcer Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Drug Class
        • 9.3.4.2.2. By Formulation
        • 9.3.4.2.3. By Indication
    • 9.3.5. Australia Mouth Ulcer Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Drug Class
        • 9.3.5.2.2. By Formulation
        • 9.3.5.2.3. By Indication

10. South America Mouth Ulcer Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Class
    • 10.2.2. By Formulation
    • 10.2.3. By Indication
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Mouth Ulcer Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Class
        • 10.3.1.2.2. By Formulation
        • 10.3.1.2.3. By Indication
    • 10.3.2. Argentina Mouth Ulcer Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Class
        • 10.3.2.2.2. By Formulation
        • 10.3.2.2.3. By Indication
    • 10.3.3. Colombia Mouth Ulcer Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Class
        • 10.3.3.2.2. By Formulation
        • 10.3.3.2.3. By Indication

11. Middle East and Africa Mouth Ulcer Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Drug Class
    • 11.2.2. By Formulation
    • 11.2.3. By Indication
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Mouth Ulcer Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Drug Class
        • 11.3.1.2.2. By Formulation
        • 11.3.1.2.3. By Indication
    • 11.3.2. Saudi Arabia Mouth Ulcer Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Drug Class
        • 11.3.2.2.2. By Formulation
        • 11.3.2.2.3. By Indication
    • 11.3.3. UAE Mouth Ulcer Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Drug Class
        • 11.3.3.2.2. By Formulation
        • 11.3.3.2.3. By Indication

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. 3M Company
  • 14.2. GlaxoSmithKline, plc
  • 14.3. Bristol-Myers Squibb Company
  • 14.4. Colgate Palmolive Company
  • 14.5. Blistex Inc
  • 14.6. Church & Dwight Co, Inc.
  • 14.7. Dr. Reddy's Laboratories Limited
  • 14.8. Patterson Dental Supply Inc.
  • 14.9. Pfizer Inc.
  • 14.10. Prince Care Pharma Private Limited

15. Strategic Recommendations